← Tickers · VRTX

VRTX

★
Vertex Pharmaceuticals Incorporated
$542.50
-1.19% today
52w $406.67-$568.67 ·P/E n/a ·Cap - ·Beta -
200D SMA
▲ 481.17
8D EMA
▲ 539.50
1D5D1M6M1Y
399443488532577542.50
Rev YoY
12%
ttm
Rev acc
-3pp
vs prior FY
Net margin
31%
ttm
ROIC
25%
elite
WACC
6%
est
Newswire· This week4 scored
This week
$VRTX raises FY26 revenue guide; opex steps up on Crinetics
Vertex Q3 revenue $3.44B but EPS misses
Vertex closes Crinetics Pharmaceuticals acquisition
Povetacicept PDUFA date set for November 30, 2026
Earningswho called it · result
Earnings
What's in herePro

A record of how many callers call each $VRTX earnings ahead of the print — and what the result was afterwards.

Start free →
Positioningpreview with Pro · full reader Elite
Convictionnewest call 64d ago
No consensus
0 of 5 agree
long 0neutral 5short 0

The graded crowd leans no consensus.

Open for positions, theses & research →
Options Tape
What's in hereElite

The calls-vs-puts lean on $VRTX, IV rank, the implied move and this week's unusual premium.

Start free →
Financialspreview with Pro · full reader Elite
SEC Filings
What's in herePro

What Vertex Pharmaceuticals Incorporated's filings actually say: revenue mix, the tone of guidance, and the risks buried in the fine print.

Preview with Pro · full reader EliteStart free →
Debt
What's in herePro

Every bond, lease and credit line: when each comes due, and whether cash on hand covers it.

Preview with Pro · full reader EliteStart free →
Congress
What's in hereElite

Which senators and representatives traded $VRTX: the dates, the sizes, and which way they leaned.

Start free →
Institutional
What's in hereElite

Which smart-money funds built, added to, or trimmed their $VRTX stake last quarter.

Start free →
Wall Street
What's in hereElite

Every analyst rating and price target on $VRTX, and how they have shifted over time.

Start free →
Insider
What's in hereElite

Every Form 4: insider buys, sells, and which sales were pre-planned months ahead.

Start free →
Earnings Informants· before the print
Pro
1 experts call $VRTX before the print. See who, how early, and their hit rate after earnings.
Start free →
1 experts
Bag Handlers
What's in herePro

Who turned bearish on $VRTX before the drop — and how early they called it.

Start free →
Knife Catchers
What's in herePro

Who bought $VRTX near the washout low, and whether the catch actually worked.

Start free →

On $VRTX a hit means +3% before −4.8%, inside 7 days. The target scales with how much a ticker usually moves, so it is tighter on steady names and wider on volatile ones.

Frequently asked questions

What is the consensus on $VRTX?

Influencer consensus on $VRTX (Vertex Pharmaceuticals Incorporated) currently shows no strong signal. SignalSnitch tracks 5 traders across X, Reddit, StockTwits and YouTube; over the last 30 days 0% of their trades were bullish and 0% bearish.

Is $VRTX a buy or a sell right now?

Across tracked influencers, $VRTX has 0 recent buy calls versus 0 sell calls — a read that shows no strong signal. SignalSnitch reports what callers are saying and how accurate they've been; it is not a buy or sell recommendation.

How many traders are tracking $VRTX?

SignalSnitch is tracking 5 traders on $VRTX, with 0 calls in the last 7 days and 0 in the last 30. Every call is graded against real prices, so the consensus reflects accountable traders rather than volume.

How does SignalSnitch grade $VRTX calls?

SignalSnitch captures every public call on $VRTX from tracked traders, then follows the price for 7 days. A hit means the price reached the target before the stop inside 7 days; calls that reached neither are left out. The target is set from how much $VRTX usually moves, so it is not the same number on every ticker. The full grading method is published openly.

Updated November 6, 2026